California State Teachers Retirement System Has $35.27 Million Stake in STERIS plc $STE

California State Teachers Retirement System reduced its stake in shares of STERIS plc (NYSE:STE - Free Report) by 2.1% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 167,485 shares of the medical equipment provider's stock after selling 3,591 shares during the quarter. California State Teachers Retirement System owned about 0.17% of STERIS worth $35,267,316 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Measured Wealth Private Client Group LLC purchased a new position in shares of STERIS in the 4th quarter worth approximately $28,000. Western Wealth Management LLC bought a new stake in shares of STERIS in the 1st quarter worth about $25,000. Elevation Wealth Partners LLC increased its holdings in shares of STERIS by 1,130.0% in the 2nd quarter. Elevation Wealth Partners LLC now owns 123 shares of the medical equipment provider's stock valued at $26,000 after acquiring an additional 113 shares during the period. Meramec Financial Planners LLC acquired a new stake in shares of STERIS during the 1st quarter worth approximately $33,000. Finally, Lloyd Advisory Services LLC. purchased a new stake in STERIS during the 4th quarter valued at about $38,000. Institutional investors own 94.69% of the company's stock.

STERIS Trading Down 0.4%

Shares of NYSE:STE traded down $0.85 during trading on Tuesday, hitting $212.81. The company had a trading volume of 259,251 shares, compared to its average volume of 772,227. The stock has a market cap of $20.75 billion, a price-to-earnings ratio of 26.01 and a beta of 0.91. STERIS plc has a one year low of $195.14 and a one year high of $269.44. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.91 and a quick ratio of 1.35. The company has a fifty day simple moving average of $225.56 and a two-hundred day simple moving average of $220.73.

STERIS (NYSE:STE - Get Free Report) last released its quarterly earnings results on Wednesday, August 5th. The medical equipment provider reported $2.59 earnings per share for the quarter, topping the consensus estimate of $2.49 by $0.10. The firm had revenue of $1.49 billion during the quarter, compared to the consensus estimate of $1.49 billion. STERIS had a net margin of 13.34% and a return on equity of 14.34%. The company's revenue for the quarter was up 7.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.34 EPS. STERIS has set its FY 2027 guidance at 11.000-11.300 EPS. As a group, equities analysts forecast that STERIS plc will post 11.09 earnings per share for the current year.

STERIS Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, September 25th. Shareholders of record on Friday, September 4th will be paid a dividend of $0.69 per share. This is a positive change from STERIS's previous quarterly dividend of $0.63. This represents a $2.76 dividend on an annualized basis and a yield of 1.3%. The ex-dividend date is Friday, September 4th. STERIS's dividend payout ratio is 33.74%.

Analysts Set New Price Targets

STE has been the topic of a number of recent analyst reports. UBS Group dropped their price objective on STERIS from $275.00 to $270.00 and set a "buy" rating on the stock in a report on Friday, August 7th. Piper Sandler reiterated an "overweight" rating and issued a $275.00 price objective (up from $270.00) on shares of STERIS in a report on Friday, August 7th. Wall Street Zen raised shares of STERIS from a "hold" rating to a "buy" rating in a report on Sunday, August 9th. Finally, Weiss Ratings reissued a "hold (c)" rating on shares of STERIS in a research report on Monday, August 24th. Three analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $271.33.

Insider Buying and Selling

In related news, Director Mohsen Sohi sold 4,058 shares of the company's stock in a transaction on Wednesday, August 12th. The stock was sold at an average price of $235.78, for a total transaction of $956,795.24. Following the completion of the sale, the director owned 24,305 shares in the company, valued at approximately $5,730,632.90. This represents a 14.31% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Company insiders own 1.12% of the company's stock.

About STERIS

STERIS plc NYSE: STE is a global provider of products and services designed to support infection prevention, sterilization, surgical procedures and other critical healthcare and life sciences activities. The company serves hospitals, ambulatory surgery centers, dental practices, pharmaceutical and biotechnology manufacturers, medical device companies, and research organizations.

Its offerings include sterilizers, washers, surgical tables and lights, operating-room equipment, endoscopy products, infection-prevention consumables, and related maintenance and technical services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.